51 Quotes by Tim Anderson

Pfizer is using curious language to describe 2006, saying 'while we are pleased that 2005 exceeded previous expectations, investors should be aware that the factors driving performance may differ materially in 2006. We are not sure what to make of this choice of words.

Half a dozen will jump in fairly quickly.

I think that the FDA will follow up with full approval,

I think that the stock's probably washed out for a while,

Our hope (in this case) is we will get a cold hit, ... It's important that we put this case to rest.

I'm hoping they'll come out with more than they did on Jan. 20, when they weren't as forthcoming as I was hoping.

Merck tells an interesting story, yet the five-year revenue and earnings growth guidance seems far-fetched.

While the company beat earnings (expectations), sale for several key franchises lagged our estimates.

While the breast cancer data is interesting, we don't think it will translate into a significant new revenue stream.